Journal of Nephrology Advances
Open Access
Acute Bilateral Hydro Nephrosis after the Use of Dapagliflozin
Feb 2016 DOI 10.14302/issn.2574-4488.jna-15-712
Bassam BerniehCorresponding author
Background Dapagliflozin; the new oral hypoglycemic agent; is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that acts by inhibiting glucose reabsorption in the proximal tubule of the nephron. Main reported side effects are osmotic diuresis, dehydration, urinary tract and genital infections. Her…